mannose has been researched along with Multiple Sclerosis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gomez, CS; Jahromi, MS; Mure, A | 1 |
| Chataway, J; Curtis, C; Gonzales, G; Haslam, C; Pakzad, M; Panicker, JN; Phé, V; Porter, B | 1 |
1 review(s) available for mannose and Multiple Sclerosis
| Article | Year |
|---|---|
UTIs in patients with neurogenic bladder.
Topics: Administration, Intravesical; Anti-Bacterial Agents; Anti-Infective Agents, Urinary; Antibiotic Prophylaxis; Antioxidants; Ascorbic Acid; Botulinum Toxins, Type A; Catheter-Related Infections; Escherichia coli; Escherichia coli Infections; Humans; Immunotherapy, Active; Mannose; Methenamine; Multiple Sclerosis; Neuromuscular Agents; Proanthocyanidins; Probiotics; Recurrence; Spinal Cord Injuries; Urinary Bladder, Neurogenic; Urinary Catheterization; Urinary Catheters; Urinary Tract Infections | 2014 |
1 other study(ies) available for mannose and Multiple Sclerosis
| Article | Year |
|---|---|
Open label feasibility study evaluating D-mannose combined with home-based monitoring of suspected urinary tract infections in patients with multiple sclerosis.
Topics: Anti-Bacterial Agents; Feasibility Studies; Female; Humans; Male; Mannose; Middle Aged; Multiple Sclerosis; Patient Compliance; Urinary Tract Infections | 2017 |